https://www.taxtmi.com/news?id=55091 Licences were granted following an expression of interest to transfer technology for commercialisation of an indigenous multi-stage recombinant malaria vaccine targeting Plasmodium falciparum; the transfer authorises five manufacturers to produce the vaccine, which was pre-clinically validated in collaboration with research institutes and is described as affordable, scalable and thermostable at room temperature to reduce infection and community transmission. en-us Tue, 09 Sep 2025 17:01:05 +0530 Tue, 09 Sep 2025 17:01:05 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=55091 Licences were granted following an expression of interest to transfer technology for commercialisation of an indigenous multi-stage recombinant malaria vaccine targeting Plasmodium falciparum; the transfer authorises five manufacturers to produce the vaccine, which was pre-clinically validated in collaboration with research institutes and is described as affordable, scalable and thermostable at room temperature to reduce infection and community transmission. News - Tue, 09 Sep 2025 17:01:05 +0530 https://www.taxtmi.com/news?id=55091